Literature DB >> 26987470

Non-nociceptive pain in rheumatoid arthritis is frequent and affects disease activity estimation: cross-sectional data from the FRAME study.

A W Christensen1, S Rifbjerg-Madsen1, R Christensen1, L Dreyer2, H Tillingsøe2, S Seven3, M Boesen1,4, K Ellegaard1, H Bliddal1, B Danneskiold-Samsøe1, K Amris1.   

Abstract

BACKGROUND: The painDETECT questionnaire (PDQ) is a mechanism-based pain classification tool assigning patients to one of three categories depending on the quality of the experienced pain. Patients with non-nociceptive pain score high on the PDQ. The objective was to assess the proportions of the three PDQ classification groups in patients with rheumatoid arthritis (RA) and to explore differences in clinical characteristics.
METHOD: RA patients initiating or escalating their RA therapy were included prospectively and underwent a thorough examination programme. Low (PDQ score < 13), medium (PDQ score 13-18), and high (PDQ score > 18) scores indicate nociceptive, unclear/possible neuropathic, or neuropathic pain mechanisms, respectively.
RESULTS: The 102 included patients were classified into the following PDQ classification groups: low = 65%, medium = 23%, and high = 12%. Patients in the medium and high PDQ groups scored worse on indicators of anxiety, depression, disability, mental health-related quality of life, pain, and fatigue. They also had more tender points and an RA disease activity score based on 28 joints (DAS28) where a higher fraction of the composite score pertained to non-inflammatory factors compared to patients in the low PDQ classification group. There were no differences in objective inflammatory indices across groups. Multiple regression analysis demonstrated that the tender joint count (TJC) and the 36-item Short Form Health Survey (SF36) mental component summary (MCS) score were independently associated with the PDQ score.
CONCLUSIONS: In patients initiating or intensifying medical treatment for their RA, non-nociceptive pain (PDQ score ≥ 13) is common. In these patients, the pain mechanisms result in increased disease activity scores on a non-inflammatory basis.

Entities:  

Mesh:

Year:  2016        PMID: 26987470     DOI: 10.3109/03009742.2016.1139174

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  14 in total

1.  Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.

Authors:  Sarah Twigg; Elizabeth M A Hensor; Paul Emery; Alan Tennant; Ann W Morgan
Journal:  J Rheumatol       Date:  2017-07-01       Impact factor: 4.666

Review 2.  [Rheumatic diseases and neuropathic pain : Diagnosis and treatment].

Authors:  J Lassen; R Baron
Journal:  Z Rheumatol       Date:  2020-12-23       Impact factor: 1.372

3.  Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.

Authors:  Kyeong Min Son; Sung Yeon Lee; Young Il Seo; Ji-Eun Choi; Hyun Ah Kim
Journal:  Clin Rheumatol       Date:  2017-04-27       Impact factor: 2.980

Review 4.  Contribution of P2X4 receptor in pain associated with rheumatoid arthritis: a review.

Authors:  Nurul Ajilah Mohamed Khir; Ain' Sabreena Mohd Noh; Nazlahshaniza Shafin; Che Aishah Nazariah Ismail
Journal:  Purinergic Signal       Date:  2021-02-17       Impact factor: 3.765

5.  Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.

Authors:  Rikke Asmussen Andreasen; Lars Erik Kristensen; Torkell Ellingsen; Robin Christensen; Xenofon Baraliakos; Jimmi Wied; Claus Aalykke; Thomas Ulstrup; Berit Schiøttz-Christensen; Hans Christian Horn; Amir Emamifar; Bent Duerlund; Lars Fischer; Inger Marie Jensen Hansen
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

6.  The Reliability of Disease Activity Score in 28 Joints-C-Reactive Protein Might Be Overestimated in a Subgroup of Rheumatoid Arthritis Patients, When the Score Is Solely Based on Subjective Parameters: A Cross-sectional, Exploratory Study.

Authors:  Inger Marie Jensen Hansen; Rikke Asmussen Andreasen; Mark Nam van Bui Hansen; Amir Emamifar
Journal:  J Clin Rheumatol       Date:  2017-03       Impact factor: 3.517

7.  The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study.

Authors:  Signe Rifbjerg-Madsen; Anton Wulf Christensen; Mikael Boesen; Robin Christensen; Bente Danneskiold-Samsøe; Henning Bliddal; Lene Dreyer; Henning Locht; Kirstine Amris
Journal:  Arthritis Res Ther       Date:  2018-05-30       Impact factor: 5.156

Review 8.  Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis.

Authors:  Stephen J Duffield; Natasha Miller; Sizheng Zhao; Nicola J Goodson
Journal:  Rheumatology (Oxford)       Date:  2018-08-01       Impact factor: 7.580

9.  Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study.

Authors:  Anna Eberhard; Stefan Bergman; Thomas Mandl; Tor Olofsson; Maria Rydholm; Lennart Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.156

10.  Patients with Rheumatoid Arthritis and Chronic Pain Display Enhanced Alpha Power Density at Rest.

Authors:  Francisco M Meneses; Fernanda C Queirós; Pedro Montoya; José G V Miranda; Selena M Dubois-Mendes; Katia N Sá; Cleber Luz-Santos; Abrahão F Baptista
Journal:  Front Hum Neurosci       Date:  2016-08-04       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.